Cocoa Extract-enriched Meals and Cardiovascular Risk in Older Population
Study of the Effect of Ready-cooked Meals Containing Cocoa Extract, as a Potential Functional Ingredient, on Cardiovascular Risk Markers in Older Population
1 other identifier
interventional
50
1 country
1
Brief Summary
Obesity prevalence in elderly populations has increased in the last years, and the reduction of overweight and obesity is a priority target in populations of all age ranges worldwide. Obesity is a disease frequently accompanied by a pro-inflammatory state, in which metabolic functions may be compromised, and therefore there is a risk of developing comorbidities such as type-2 diabetes, hyperlipidemias, hypertension, atherosclerosis, etc. In this context, plant extracts are a good source of antioxidant compounds. Among these compounds, polyphenols have been shown to have an important antioxidant effect. Scientific evidence based on epidemiological studies suggest that flavonoids from the diet play an important role on the prevention of cardiovascular disease. Cocoa and related products are an important source of flavonoids, providing even more than tea or wine. Generally, benefits associated to cocoa consumption are related to the ability for improving lipid profile and insulin sensitivity, reducing blood pressure, platelet activity and improving endothelial dysfunction. Some studies have also shown an improvement of inflammatory conditions, mainly due to the capacity of the polyphenols contained to modify cellular transcription, and the secretion of proinflammatory cytokines in peripheral blood mononuclear cells, macrophages and lymphocytic strains. Therefore, the hypothesis of this study is that the consumption of cocoa extract-enriched prepared meals, within a hypocaloric diet, will help to reduce body weight and to improve cardiovascular risk factors compared to the same diet with standard prepared meals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 9, 2012
CompletedFirst Posted
Study publicly available on registry
May 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJune 18, 2013
September 1, 2012
6 months
May 9, 2012
June 17, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline of Plasma Oxidized LDL
Levels of LDL-ox in plasma will be analysed at the beginning and the end (4 weeks) of each intervention period
Baseline and 4 weeks
Secondary Outcomes (35)
Change from baseline of fat mass content
Baseline and 4 weeks
Change from baseline of waist circumference
Baseline and 4 weeks
Change from baseline of hip circumference
Baseline and 4 weeks
Height
Baseline
Change from baseline of body weight
Baseline and 2 weeks
- +30 more secondary outcomes
Study Arms (2)
control group, placebo
PLACEBO COMPARATORThis period will consist on a structured personalised hypocaloric diet containing ready prepared meals without extract added
Intervention group, cocoa extract
EXPERIMENTALThis period will consist on a structured personalised hypocaloric diet containing ready prepared meals with cocoa extract added. Final cocoa extract daily intake will be of 1.4 g.
Interventions
Participants will follow a hypocaloric diet during two periods of 4 weeks, each. Within these diets, participants will consume daily 2 ready prepared frozen meals containing cocoa extract (0.7 g per meal; 1.4g per day) or nothing (placebo).
Eligibility Criteria
You may qualify if:
- Body Mass Index between 27 and 35.5 kg/m2
- Subjects with central adiposity (waist circumference over 94 cm in males and 80 cm in females)
- Subjects presenting insulin resistance non pharmacologically treated
- Subjects presenting hyperlipidemia non pharmacologically treated
You may not qualify if:
- Subjects following dietotherapy to loose weight at the moment of the study or in the past three months.
- Subjects with variations of weight greater than 5% of their body weight in the last three months).
- Subjects with deficient nutritional or hydration status.
- Subjects suffering from chronic diseases such as cancer, diabetes, hyperlipidemia, etc.
- Subjects with functional or structural impairments in digestive tract (peptic ulcer, malabsorption syndrome, inflammatory state, etc.)
- Subjects having gone under digestive surgery and have permanent consequences.
- Subjects suffering from allergy to cocoa or derived products.
- Subjects being physically or psychologically affected, with difficulties to attend the facilities with the required frequency.
- Smokers and frequent (more than 3 portions of beer/wine/spirits per day in males and 2 portions of beer/wine/spirits per day in females)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Nutrition, Food Science, Physiology and Toxicology. University of Navarra
Pamplona, Navarre, 31008, Spain
Related Publications (4)
Ibero-Baraibar I, Perez-Cornago A, Ramirez MJ, Martinez JA, Zulet MA. An Increase in Plasma Homovanillic Acid with Cocoa Extract Consumption Is Associated with the Alleviation of Depressive Symptoms in Overweight or Obese Adults on an Energy Restricted Diet in a Randomized Controlled Trial. J Nutr. 2015 Apr 1;146(4):897S-904S. doi: 10.3945/jn.115.222828.
PMID: 26962189DERIVEDIbero-Baraibar I, Azqueta A, Lopez de Cerain A, Martinez JA, Zulet MA. Assessment of DNA damage using comet assay in middle-aged overweight/obese subjects after following a hypocaloric diet supplemented with cocoa extract. Mutagenesis. 2015 Jan;30(1):139-46. doi: 10.1093/mutage/geu056.
PMID: 25527736DERIVEDIbero-Baraibar I, Navas-Carretero S, Abete I, Martinez JA, Zulet MA. Increases in plasma 25(OH)D levels are related to improvements in body composition and blood pressure in middle-aged subjects after a weight loss intervention: Longitudinal study. Clin Nutr. 2015 Oct;34(5):1010-7. doi: 10.1016/j.clnu.2014.11.004. Epub 2014 Nov 11.
PMID: 25434574DERIVEDIbero-Baraibar I, Abete I, Navas-Carretero S, Massis-Zaid A, Martinez JA, Zulet MA. Oxidised LDL levels decreases after the consumption of ready-to-eat meals supplemented with cocoa extract within a hypocaloric diet. Nutr Metab Cardiovasc Dis. 2014 Apr;24(4):416-22. doi: 10.1016/j.numecd.2013.09.017. Epub 2013 Nov 1.
PMID: 24462367DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
J. Alfredo Martinez, PhD, RN
University of Navarra, Pamplona, Spain
- STUDY CHAIR
M. Angeles Zulet, PhD
University of Navarra, Pamplona, Spain
- STUDY CHAIR
Santiago Navas-Carretero, PhD
University of Navarra, Pamplona, Spain
- STUDY CHAIR
Idoia Ibero, M. Sc
University of Navarra, Pamplona, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Nutrition and Bromatology
Study Record Dates
First Submitted
May 9, 2012
First Posted
May 10, 2012
Study Start
January 1, 2012
Primary Completion
July 1, 2012
Study Completion
December 1, 2012
Last Updated
June 18, 2013
Record last verified: 2012-09